New AI platform helps uncover promising cancer drug combinations
UCLA investigators have developed a new artificial intelligence-based platform that could help scientists identify promising drug combinations to overcome treatment resistance in cancer.
Read original article on Medical Xpress - latest medical and health news stories →Related news
-
Intermittent fasting plus exercise boosts fat loss and fitness in 12-week obesity trial
United Kingdom
-
Prevalence of binge eating 40.5% in U.S. high school students
United Kingdom
-
Common multiple sclerosis treatment linked to bowel disease risk
United Kingdom
-
Clinical trial establishes effective HIV dosing regimen for full-term newborns
United Kingdom
-
Baylor Scott & White Health and Thrive Global partner to enhance customer well-being
United Kingdom
-
International study helps support FDA approval of HIV drug for newborns
United Kingdom
-
Unstable immune cells linked to severe cancer immunotherapy side effects
United Kingdom
-
Transplanted placental cells successfully detected in mouse pancreas after birth
United Kingdom